New study in mice by University of Illinois researchers finds that the compounds in thermally abused cooking oils may trigger genetic, biochemical changes that hasten the progression of late-stage breast cancer, promoting tumor cells' growth and proliferation.
A researcher in the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine, working in collaboration with researchers from the University of Maryland, recently reported several important findings related to triple negative breast cancer and its future treatment in the journal Nature Nanotechnology.
State breast density notification laws that mandate reporting of mammogram results can prompt further screening and modestly boost cancer detection rates, say researchers at Yale's School of Public Health and School of Medicine. Their study was published in the American Journal of Public Health.
A novel precision medicine strategy described in Science Advances offers an intriguing ray of hope for triple-negative breast cancer. The proof-of-concept study shows that dually-targeted, antibody-guided nanoparticles, loaded with an existing chemotherapy drug, markedly improved tumor targeting, decreased tumor and metastatic growth and dramatically improved survival in a mouse model -- with no observable side effects.
The use of digital breast tomosynthesis, also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study.
Fewer women are assigned to a dense breast category when evaluated with advanced mammographic screening technologies compared to standard digital mammography, according to a new study.
Death rates from breast cancer are predicted to fall in all European Union (EU) countries in 2019 with the exception of Poland, according to new research published in the leading cancer journal Annals of Oncology. In their annual predictions for cancer deaths in the EU, Carlo La Vecchia and colleagues predict there will be 1.4 million deaths from all cancers in 2019.
A team at the George Washington University Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of pancreatic cancer, as well as ovarian and breast cancers.
It has been known for decades that cancer cells have an altered metabolism and it is seen in several biochemical pathways and in particular, in the way they get energy for their survival. Now, a new article describes an epigenetic injury found in human tumours which created this altered path to take energy from the cancer.
Free fatty acids in the blood are linked with higher rates of estrogen-receptor positive breast cancer in obese postmenopausal women, according to a new study led by food science and human nutrition professor Zeynep Madak-Erdogan at the University of Illinois.